Immunoprotein Diagnostic Testing Market is Expected to Reach USD 15.4 Billion Globally in 2019:Transparency Market Research - NEWS10 ABC: Albany, New York News, Weather, Sports

Immunoprotein Diagnostic Testing Market is Expected to Reach USD 15.4 Billion Globally in 2019:Transparency Market Research

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Transparency Market Research

ALBANY, New York, May 7, 2014 /PRNewswire/ --


According to a new market report published by Transparency Market Research "Immunoprotein Diagnostic Testing Market (Radioimmunoassay, Enzyme Based Immunoassay, Chemiluminescence Assay, Immunofluorescence Assay, Immunoturbidity Assay and Immunoprotein Electrophoresis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global immunoprotein diagnostic testing market was valued at USD 11.1 billion in 2012 and is expected to grow at a CAGR of 5.7% from 2013 to 2019, to reach an estimated value of USD 15.4 billion in 2019.

Browse Immunoprotein  Diagnostic  Testing  Market Report With Full TOC at http://www.transparencymarketresearch.com/immunoprotein-diagnostic-testing.html

Immunoproteins play a vital role in launching an immune response against an antigen. These immunoproteins show a minimal serum level under normal conditions, but on exposure to antigen, their levels increase 10 to 100 fold within 24 to 48 hours. This characteristic property of immunoproteins has been exploited in the field of disease diagnosis and has now become an integral part of the healthcare sector. With the rising incidences of diseases such as cancer, diabetes, tuberculosis, malaria, and various viral infections, quick and confirmed diagnosis has become a prime need in hospitals and diagnostic centers worldwide. The aging of population has added to the number of individuals seeking medical attention and is expected to continue rising in the future. Moreover, the prevalence of allergies and autoimmune diseases whose diagnosis is even more critical is also on the rise. The collective effect of these incidences will propel the immunoprotein diagnostic testing market to grow at a CAGR of 5.7% from 2013 to 2019.

The immunoprotein diagnostic testing market has been segmented on the basis of technology into radioimmunoassay, enzyme based immunoassay, chemiluminescence assay, immunofluorescence assay, immunoturbidity assay, and immunoprotein electrophoresis. The enzyme based immunoassay segment which includes enzyme linked immunosorbent assay (ELISA) and multiplex ELISA, covers the maximum market share owing to the longstanding ELISA market. Other market segments such as chemiluminescence face challenges particularly since end users do not wish to replace already existing fully functional ELISA technology. Expensive instruments and reluctance of laboratory workers to upgrade their knowledge and technology has added to the woes of this market. But, with obsolescence of installed base and demand for better diagnostic services, the market for traditional ELISA is expected to shrink. Chemiluminescence assays are becoming increasingly popular as they are similar to ELISA; multiplex chemiluminescence assays have also become popular in the diagnostic industry.  

Growing knowhow about various cancer biomarkers coupled with innovation in biotechnology has made cancer testing easier and more accurate. Application of multiplex ELISA in cancer diagnosis has enabled simultaneous analysis of multiple biomarkers. Free Light Chain (FLC) assays by The Binding Site have been widely used in diagnosis and monitoring of patients with multiple myeloma. Enzyme multiplied immunoassay technique (EMIT) patented technology by Siemens Healthcare Diagnostics is used for toxicology testing. ImmunoCAP by Phadia, a Thermo Fisher Scientific company, has been a standard in allergy testing. Various such assay technologies have contributed in making the diagnostics market dynamic and growing.

Geographically, North America lead the market in 2012, while Asia-Pacific and Rest of the World (which comprises Africa, Middle East and Latin America) are anticipated to be the most attractive markets in the near future. Rising per capita income, increasing awareness about available medical services, and medical tourism has boosted the market growth in these nations.

 

Related  &  Recently  Published  Reports  by  Transparency  Market  Research:

Circulating  Tumor  Cells  (Ctcs)  And  Cancer  Stem  Cells  (Cscs)  Market: http://www.transparencymarketresearch.com/circulating-tumor-cells-ctcs-and-cancer-stem-cells-cscs-market.html

Cervical  Cancer  Diagnostic  Tests  Market: http://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html

Global  And  U.S.  Pharmaceutical  Packaging  Market: http://www.transparencymarketresearch.com/pharmaceutical-packaging-market.html

OSS/BSS  Market: http://www.transparencymarketresearch.com/ossbss-market.html

Home  Automation  Market: http://www.transparencymarketresearch.com/home-automation-market.html

 

The global immunoprotein diagnostic testing market is segmented as follows:

Immunoprotein  Diagnostic  Testing  Market,  by  Technology

  • Radioimmunoassay
  • Enzyme based immunoassay
  • Chemiluminescence assay
  • Immunofluorescence assay
  • Immunoturbidity assay
  • Immunoprotein electrophoresis

Immunoprotein  Diagnostic  Testing  Market,  by  Immunoprotein  Type

  • Complement system protein diagnostic tests
  • Free Light Chain diagnostic tests
  • Haptoglobin diagnostic tests
  • Immunoglobulin diagnostic tests
  • Prealbumin diagnostic tests
  • C-reactive protein diagnostic tests

Browse Immunoprotein  Diagnostic  Testing  Market Report With Full TOC at http://www.transparencymarketresearch.com/immunoprotein-diagnostic-testing.html

 

Immunoprotein  Diagnostic  Testing  Market,  by  Application

  • Infectious Disease Testing
  • Oncology Testing
  • Endocrine Testing
  • Toxicology Testing
  • Allergy Testing
  • Autoimmune testing

Immunoprotein  Diagnostic  Testing  Market,  by  Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Browse Biotechnology  Market Reports at http://www.transparencymarketresearch.com/biotechnology-market-reports-18.html

 

About  Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Browse All Market Research Reports:  http://www.transparencymarketresearch.com/categories.html

Browse Market Research Articles: http://www.transparencymarketresearch.com/articles.htm

Browse Market Research News: http://www.transparencymarketresearch.com/press-releases.htm

Blog: http://www.tmrblog.com/

Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com


©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

341 Northern Blvd., Albany, NY 12204

Telephone: 518.436.4822
Fax: 518.426.4792
Email: news@news10.com

Can’t find something?
Powered by WorldNow
All content © Copyright 2000 - 2014 Young Broadcasting of Albany, Inc. A Media General Company.